Prostate cancer treatment outcomes, robotic techniques grabbing headlinesat this year's AUA
Over the next 5 days, urologists can expect to hear a great deal aboutprostate cancer treatment outcomes, robotic and minimally invasive surgicaltechniques, pelvic pain in both men and women, the obesity epidemic andits connection to prostate cancer, and advances in erectile dysfunctiontherapy. These are among the key areas of scientific research grabbing headlinesat this year's AUA annual meeting, said J. Brantley Thrasher, MD, chairof AUA's Public Media Committee.Dr. Thrasher briefed a small group of journalists yesterday on theseand other significant topics that make up part of the nearly 2,000 researchpapers being presented here.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.